IHS Chemical Week

People & Business :: Companies

Cytec beats estimates as sales rise slightly

3:29 PM MDT | October 17, 2013 | Vincent Valk

Cytec has reported third-quarter net earnings of $43.8 million, or $1.19/share, down 25% year-on-year (YOY), with sales from continuing operations totaling $464 million, up 2%. Excluding charges and discontinued operations, adjusted earnings from continuing operations totaled $49.4 million, or $1.34/share, up 6% and slightly ahead of analysts’ consensus estimate of $1.32/share, as reported by Thomson Reuters (New York). “Our third quarter results reflect more modest top line growth compared to the third quarter of last year as legacy large commercial...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa